Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Getting involved in DRIVE - Topi Turunen FISABIO

11 views

Published on

DRIVE Annual Forum
17th -18th September 2018, Rome

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Getting involved in DRIVE - Topi Turunen FISABIO

  1. 1. Acknowledgement DRIVE project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777363, This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. Getting involved in DRIVE Acknowledgement DRIVE project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777363, This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. Topi Turunen, MD FISABIO-Public Health
  2. 2. Sites in 2018/19 PHIs & NICs • Austria • Finland • Italy • Romania • Spain-Valencia • Spain-La Rioja • [An additional NPHI] Universities & networks • Bambino Gesu children’s hospital (IT) • CIRI-IT (IT) • Helsinki Uni. Central Hospital (FI) • Kapodistrian University of Athens (GR) • Uni. Surrey (UK) • Vall d’Hebron Uni. Hospital (ES) • [An European network] ??
  3. 3. Test-negative design studies Cohort studies Novel & innovative studies
  4. 4. Public organizations with established IVE studies Other research organizations Associate partners Research collaborators Annual call for tenders Review by DRIVE SC
  5. 5. IVE studies & sharing data DRIVE annual meetings Scientific discussion, publications Development of innovative methodology Associated Partners and Research Collaborators receive a compensation for participation in DRIVE activities They retain the full ownership of their data
  6. 6. • Ethics Committee reviews for each study are handled locally • Data collection should be compatible with one of the DRIVE research protocols (with the exception of innovative studies) • DRIVE accepts both individual-level pseudonymised data and aggregated/anonymised data
  7. 7. www.drive-eu.org Acknowledgement DRIVE project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777363, This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. info@drive-eu.org @drive_eu

×